https://www.selleckchem.com/pr....oducts/gilteritinib-
32; 95% CI 0.20, 0.5, whereas stent-type TATs showed no benefit in the rate of reoperation (OR 0.79; 95% CI 0.37, 1.65). Off-the-shelf catheter-type transanal tubes appeared effective in preventing AL, whereas custom-designed stent-type TATs were not demonstrated to be effective; although high quality evidence is limited. TAT design should be an important consideration in further research of the use of TATs in anterior resection surgery. Off-the-shelf catheter-type transanal tubes appeared effective in preventing AL, wher